NEWS : :
September 2011-
Kansas City Business Journal - OsteoGeneX to Spin Off Commercialization Entity-New Chief Commercial Officer to Drive Bone Therapeutics to Market (Download press release)
July 2011-
Kansas City Business Journal - Bioscience businesses in area offer great promise, carry great risk, Kansas City (KS)
June 2011-
Kansas City Business Journal - OsteoGenex raises $1.4M more for bone-growth products research, Kansas City (KS)
May 2011-
Great Kansas City Chamber of Commerce- Nomination for the "Mr. K Award" by PIPELINE, Kansas City (KS).
Angel Capital Association- Nomination for the "Silvertip Award" by Woman Capital Connection, Kansas City (KS).
March 2011-
Kansas City Business Journal - InvestMidwest Venture Capital Forum hints at economic recovery, Kansas City (KS)
January 2011-
Demy Colton BioTech Showcase, San Francisco (CA)
|
PRODUCTS : :
Our platform represents an exceptionally rich source of small molecule candidates focused specifically on Sclerostin (SOST) and Wnt modulators for building bone.
OGX - 58 Bone Growth
OGX - 21 Bone Growth |
|
|
|
STRATEGIC ALLIANCES: :
OsteoGeneX is interested in value generating Alliances for the commercialization of our osteoporosis program. Please send your proposals to -
BDev@osteogenex.com
|
CAREERS : :
OsteoGeneX takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
We are looking to expand our team, do you demonstrate the excellence we are seeking?
Contact Us >
Laboratory Address
OsteoGeneX Inc
2002 West 39th Av.
Kansas City, KS - 66103
Tel. 913.945.6763
Fax. 913.660.0637
Corporate Address
OsteoGeneX Inc
PO Box 3132
Kansas City, KS - 66103
|
